Update: ARQ 197 – New Clinical Trial for Patients with Alveolar Soft Part Sarcoma
Previously, we reported that Alveolar Soft Part Sarcoma is a candidate for therapy by drugs that inhibit the MET receptor tyrosine kinase. Then, we reported the opening of a clinical trial of such an inhibitor, ARQ 197, in California. This clinical trial is now open in many more locations in the USA, and may soon be available in […]
iCureASPS supports ASPS Research in the laboratory of Dr. Dina Lev at MD Anderson Cancer Center
iCureASPS is looking for active members of the ASPS community to help maintaining viable collaborations with scientists who perform ASPS research in medical centers. If you wish to be part of an active search for Alveolar Soft Part Sarcoma Cure, please contact us! Such a new collaboration was recently established with Dr. Dina Lev at […]
iCureASPS Sponsors Studies on Halofuginone, a Possible Therapy for Alveolar Soft Part Sarcoma
iCureASPS has recently sent funds to sponsor an original research, which is carried out in the laboratory of Dr. Mark Pines at the Volcani Center, Bet Dagan, Israel. Halofuginone is an analog of the molecule febrifugine. Febrifugine is the active component in the extract from the roots of the Chinese herb chang shan (Dichroa febrifuga), […]
Two New Research Studies on Alveolar Soft Part Sarcoma
Two scientific publications on Alveolar Soft Part Sarcoma have been recently published: “Angiogenesis-promoting gene patterns in Alveolar Soft Part Sarcoma” by Lazar et al., 2007 (from M. D. Anderson Cancer Center) and “Immunohistochemical discrimination between the ASPL-TFE3 fusion proteins of Alveolar Soft Part Sarcoma” by Vistica et al., 2008 (from The National Cancer Center). Lazar […]
Team ASPS biked the 2007 PMC and raised funds to find a cure for ASPS
In the first week of August 2007, Team ASPS participated in the Pan-Massachusetts Challenge (PMC) bike ride for the fourth time. This bike-a-thon crosses Massachusetts to raise money for cancer research and treatment at the Dana-Farber Cancer Institute (DFCI) in Boston. Some of our riders rode 90 miles and others rode 150 miles. The money […]
ARQ 197: New Clinical Trial for Patients with Alveolar Soft Part Sarcoma
Update on the ARQ 197 Clinical Trial (November 23): The new clinical trial (read below) is now open and at least two ASPS patients are already participating in it. If you are interested to join the trial please read the information below and contact Dr. Isett Laux, the study coordinator for this study. Tel: 310-633 […]
Laser Assisted Resection of Multiple Lung Metastases
Lung metastases affect a significant part of the ASPS patients at some point of their life, they can be very multiple and wide spread. It is very important to detect them early for an optimal management so all ASPS patients have to be monitored for the possible lung metastases development. For ASPS patients the use […]
Camilla’s Story
Dear ASPS community, Below is a personal story of Camilla who was diagnosed having ASPS in 1983 and today she is cancer free. If you wish to read more of Camilla’s story and ask her questions please check our forum. More details will appear soon in the “Personal updates” section. Camilla’s Story: In 1983 I […]
iCureASPS Dedicated its July 15 Training Ride to the 2007 Team Sarcoma Initiative
(UPDATED July 29, 2007) A few weeks ago, iCureASPS team started its training for the PMC bike ride that will take place August 4-5 2007. The fundraiser to support the research and clinical trial at the Dana Farber Cancer Institute is open. Please take the initiative TODAY. Please make a donation NOW to support the efforts […]
Feedback – The GVAX Cancer Vaccine Trial at the Dana Farber
Dear ASPS community. As you probably know, the GVAX cancer vaccine clinical trial has been open since January 2006 and is still recruiting new patients. In addition to Alveolar Soft Part Sarcoma, it also recruits Clear Cell Sarcoma, Renal Cell Carcinoma and Melanoma patients. I would like to share with you an e-mail from a […]